AN-152: Additional Phase I data

Additional data from an open-label, dose-escalation, German Phase I trial in 17

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE